Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam; School of Pharmacy, Queen's University Belfast, Belfast, UK.
Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
J Hosp Infect. 2022 Sep;127:121-128. doi: 10.1016/j.jhin.2022.06.002. Epub 2022 Jun 14.
In 2016, the Vietnamese Ministry of Health promoted development of antimicrobial stewardship for hospitals.
To evaluate the effectiveness and safety of the enhanced antibiotic stewardship programme (ASP) compared to the original ASP among paediatric patients at a tertiary hospital for infectious diseases in Vietnam.
An interrupted time-series analysis was conducted to examine antibiotic use in paediatric patients aged 0-17 years admitted to the Hospital for Tropical Diseases in Ho Chi Minh City from April 2016 to March 2020. Outcomes measured were defined daily doses (DDDs) per 1000 patient-days; antibiotic days of therapy (DOT) per 1000 patient-days; percentage of antibiotic use by the World Health Organization Access, Watch, and Reserve (AWaRe) system; Access-to-Watch ratio; and worse clinical outcomes at discharge.
Of 60,172 admissions during the study period, 28,019 received at least one antibiotic (46.6%) during hospital stay. The Watch antibiotics were the most frequently prescribed (78.1% of total antibiotic courses). The enhanced ASP did not improve antibiotic prescribing by DDDs per 1000 patient-days (risk ratio: 1.05; 95% confidence interval: 0.94-1.17) and DOT per 1000 patient-days (1.11; 0.99-1.25) compared to the original ASP. However, the percentage of Access antibiotics prescribed, and the Access-to-Watch ratio increased after the enhanced ASP (1.73; 1.38-2.17). There was no significant difference in worse clinical outcomes at discharge between the original and enhanced ASP (1.25; 0.78-2.00).
The enhanced ASP had modest impact on antibiotic consumption in the paediatric population despite the improvement of Access antibiotic use and the Access-to-Watch ratio.
2016 年,越南卫生部推动了医院抗菌药物管理计划的发展。
评估强化抗生素管理计划(ASP)在越南一家传染病三级医院儿科患者中的有效性和安全性,与原始 ASP 相比。
采用中断时间序列分析,对 2016 年 4 月至 2020 年 3 月在胡志明市热带病医院住院的 0-17 岁儿科患者的抗生素使用情况进行了研究。测量的结果是每 1000 名患者天的定义日剂量(DDD);每 1000 名患者天的抗生素治疗天数(DOT);世界卫生组织获得、观察和储备(AWaRe)系统的抗生素使用率;获得至观察的比值;出院时的临床结局恶化。
在研究期间,60172 例住院患者中,28019 例在住院期间至少使用了一种抗生素(占 46.6%)。观察类抗生素是最常开的处方(占总抗生素疗程的 78.1%)。强化 ASP 并没有改善每 1000 名患者天的 DDDs (风险比:1.05;95%置信区间:0.94-1.17)和每 1000 名患者天的 DOT(1.11;0.99-1.25)的抗生素处方。然而,与原始 ASP 相比,处方中的 Access 类抗生素的比例和 Access 至观察的比值增加了(1.73;1.38-2.17)。原始和强化 ASP 之间出院时临床结局恶化的差异无统计学意义(1.25;0.78-2.00)。
尽管 Access 类抗生素的使用和 Access 至观察的比值有所改善,但强化 ASP 对儿科人群的抗生素消耗的影响不大。